Symphonix Suit Charges Soundtec With Misappropriating Trade Secrets
This article was originally published in The Gray Sheet
Soundtec should be restrained from selling its Direct System implantable middle-ear hearing device for two years and give all related profits to Symphonix Devices, according to a complaint filed in the U.S. District Court for Northern California Nov. 27
You may also be interested in...
Incorporation of advanced eight-channel digital signal processing component into the semi-implantable middle-ear hearing device gains FDA approval via PMA supplement Jan. 3. Increasing programming flexibility, the next-generation device follows the August 2000 approval of the first generation product (1"The Gray Sheet" Sept. 4, 2000, p. 7). A totally implantable device also is under development
The race is now on to get formal adoption of European Commission proposal postponing the MDR by one year and allowing more devices on the market more quickly. But potential hurdles are in the way as experts advise caution.